tiprankstipranks
Prescient Therapeutics Limited (PSTTF)
OTHER OTC:PSTTF

Prescient Therapeutics Limited (PSTTF) Financial Statements

5 Followers

Prescient Therapeutics Limited Financial Overview

Prescient Therapeutics Limited's market cap is currently ―. The company's EPS TTM is $-0.006; its P/E ratio is ―; Prescient Therapeutics Limited is scheduled to report earnings on February 23, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 12.28MAU$ 16.12MAU$ 7.38MAU$ 9.66MAU$ 5.51M
Total AssetsAU$ 17.62MAU$ 20.97MAU$ 12.07MAU$ 15.01MAU$ 9.99M
Total DebtAU$ 0.00AU$ 165.83KAU$ 156.88KAU$ 0.00AU$ 56.05K
Net DebtAU$ -12.28MAU$ -15.95MAU$ -7.22MAU$ -9.66MAU$ -5.45M
Total LiabilitiesAU$ 856.01KAU$ 539.68KAU$ 883.95KAU$ 685.79KAU$ 551.56K
Stockholders EquityAU$ 16.76MAU$ 20.43MAU$ 11.19MAU$ 14.32MAU$ 9.44M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Prescient Therapeutics Limited Earnings and Revenue History

Prescient Therapeutics Limited Debt to Assets

Prescient Therapeutics Limited Cash Flow

Prescient Therapeutics Limited Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis